[1] |
朱铭力,郦忆,钱家麒,等.肝移植术后患者预后不良的独立危险因素分析.中国危重病急救医学, 2009, 21(2):69-73.
|
[2] |
林洪远,管向东,周立新,等.乌司他丁、α1胸腺肽联合治疗严重脓毒症——一种新的免疫调理治疗方法的临床研究.中华医学杂志, 2007, 87(7):451-457.
|
[3] |
Cakir M, Arikan C, Akman SA, et al. Infectious complications in pediatric liver transplantation candidates. Pediatr Transplant, 2010, 14(1):82-86.
|
[4] |
李敏如,汪根树,张琪,等.肝移植术后早期合并脓毒症患者外周血炎症因子的变化特点.器官移植, 2012, 3(2):102-105.
|
[5] |
郭庆良,卢实春,王孟龙,等.影响慢性重型肝炎肝移植生存率的相关危险因素分析.中华肝胆外科杂志, 2008, 14(6):374-377.
|
[6] |
曲明,王营,史彦芬,等.重型肝炎肝移植围手术期处理相关问题探讨(附42例报告).器官移植, 2011, 2(2):68-72.
|
[7] |
Shepherd RW, Turmelle Y, Nadler M, et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant, 2008, 8(2):396-403.
|
[8] |
Amirzargar A, Lessanpezeshki M, Fathi A, et al. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc, 2005, 37(7):2985-2987.
|
[9] |
Kessel A, Bamberger E, Masalha M, et al. The role of T regulatory cells in human sepsis. J Autoimmun, 2009, 32(3/4):211-215.
|
[10] |
Billerbeck E, Bottler T, Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol, 2007, 13(36):4858-4864.
|
[11] |
You J, Zhuang L, Zhang YF, et al. Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load. World J Gastroenterol, 2009, 15(27):3382-3393.
|
[12] |
Shalev I, Wong KM, Foerster K, et al. The novel CD4+ CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology, 2009, 49(2):387-397.
|
[13] |
Yoshizawa K, Abe H, Kubo Y, et al. Expansion of CD4(+)CD25(+) FoxP3(+) regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol Res, 2010, 40(2):179-187.
|
[14] |
孙庆丰,戴美勇,陈威,等. T淋巴细胞亚群与慢性乙型重型肝炎患者继发细菌感染及预后的关系.中华肝脏病杂志, 2008, 16(2):146-147.
|
[15] |
Wasmuth HE, Kunz D, Yagmur E, et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol, 2005, 42(2):195-201.
|
[16] |
Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol, 2006, 177(1):739-747.
|
[17] |
He Q, Fan H, Li JQ, et al. Decreased circulating CD4+ CD25highFoxp3+ T cells during acute rejection in liver transplant patients. Transplant Proc, 2011, 43(5):1696-1700.
|
[18] |
Chen Y, Chen J, Liu Z, et al. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc, 2008, 40(8):2691-2695.
|
[19] |
Karczewski J, Karczewski M, Glyda M, et al. Role of TH1/TH2 cytokines in kidney allograft rejection. Transplant Proc, 2008, 40(10):3390-3392.
|
[20] |
Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol, 2008, 48(Suppl 1):S20-S37.
|
[21] |
Amirzargar A, Lessanpezeshki M, Fathi A, et al. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc, 2005, 37(7):2985-2987.
|